GKB Ophthalmics Ltd (GKB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 360373, "name": "GKB Ophthalmics", "stock_name": "GKB Ophthalmics", "full_name": "GKB Ophthalmics Ltd", "name_url": "stocks-analysis/gkb-ophthalmics", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "52.50", "chg": -1.62, "chgp": "-2.99%", "dir": -1, "prev_price": "54.12", "mcapval": "27.00 Cr", "mcap": "Micro Cap", "scripcode": 533212, "symbol": "GKB", "ind_name": "Healthcare Services", "ind_code": 31, "indexname": "India SENSEX", "isin": "INE265D01015", "curr_date": "Mar 30", "curr_time": "", "bse_nse_vol": "1.01 k", "exc_status": "Active", "traded_date": "Mar 30, 2026", "traded_date_str": "2026 03 30", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gkb-ophthalmics-360373-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "GKB Ophthalmics Surges 11.46% Amid Strong Quarterly Revenue and Mixed Profit Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-surges-1146-amid-strong-quarterly-revenue-and-mixed-profit-signals-3840214", "imagepath": "", "date": "2026-02-14 17:16:40", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Feb 9:</strong> Stock opens at Rs.53.33, down 2.82% amid broader Sensex gains</p>\n <p><strong>Feb 11:</strong> Stock rebounds sharply, gaining 5.68% to Rs.56.00</p>\n <p><strong>Feb 13:</strong> Quarterly results released; stock surges 10.92% to Rs.61.17</p>\n <p><strong>Feb 13:</strong> Week closes with 11.46% gain despite Sensex decline</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.54.88</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"sta..." }, { "title": "Are GKB Ophthalmics Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-gkb-ophthalmics-ltd-latest-results-good-or-bad-3838178", "imagepath": "", "date": "2026-02-13 19:54:33", "description": "GKB Ophthalmics Ltd's latest financial results for Q3 FY26 present a complex picture of operational performance. The company reported a significant revenue surge, with net sales reaching ₹56.79 crores, marking an 88.23% increase compared to the previous quarter. This growth represents the highest quarterly revenue in at least two years, indicating strong demand for its products.\n\nHowever, this impressive revenue growth did not translate into profitability, as the consolidated net profit fell to ₹0.44 crores, reflecting a 72.50% decline from the prior quarter. The operating margin also saw a substantial contraction, dropping to 2.39% from 10.11% in Q2 FY26, suggesting challenges in maintaining cost efficiency amidst rising sales. The PAT margin compressed to 1.25%, indicating difficulties in controlling costs despite increased sales volumes.\n\nThe financial results highlight a concerning trend of deterioratin..." }, { "title": "GKB Ophthalmics Ltd Reports Very Positive Quarterly Financial Performance Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-ltd-reports-very-positive-quarterly-financial-performance-amid-market-volatility-3837400", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GKBOphthalmicsL_fintrenddot_3837400.png", "date": "2026-02-13 11:00:17", "description": "GKB Ophthalmics Ltd has demonstrated a marked improvement in its financial performance for the quarter ended December 2025, signalling a very positive shift in its growth trajectory despite broader market challenges. The company’s latest results reveal robust revenue expansion and a notable rise in profitability, contrasting with its historical trends and outperforming key market benchmarks." }, { "title": "GKB Ophthalmics Q3 FY26: Revenue Surge Masks Persistent Profitability Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/gkb-ophthalmics-q3-fy26-revenue-surge-masks-persistent-profitability-concerns-3837659", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GKBOphthalmics_quaterlyResult_3837659.png", "date": "2026-02-13 09:25:33", "description": "GKB Ophthalmics Ltd., a Goa-based ophthalmic solutions manufacturer, reported a consolidated net profit of ₹0.44 crores for Q3 FY26, plunging 72.50% sequentially from ₹1.60 crores in Q2 FY26, despite an impressive 88.23% quarter-on-quarter revenue surge. The micro-cap healthcare services company, with a market capitalisation of ₹31.42 crores, saw its stock rally 13.04% to ₹62.34 following the results announcement, though it remains 32.02% below its 52-week high of ₹91.70." }, { "title": "Are GKB Ophthalmics Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-gkb-ophthalmics-ltd-latest-results-good-or-bad-3835705", "imagepath": "", "date": "2026-02-12 19:45:53", "description": "GKB Ophthalmics Ltd's latest financial results for Q2 FY26 present a complex picture of operational performance. The company reported a consolidated net profit of ₹1.60 crores, which marks a significant turnaround from a net loss of ₹1.02 crores in the previous quarter, though it reflects a substantial decline of 231.15% year-on-year. This profit, while positive in the context of the previous quarter, highlights the volatility in the company's financial performance.\n\nOn the revenue front, GKB Ophthalmics generated ₹30.17 crores, which represents a quarter-on-quarter decline of 6.62% compared to ₹32.31 crores in the previous quarter, but shows a year-on-year growth of 15.42%. This revenue growth suggests some resilience in topline performance despite the recent quarterly drop.\n\nThe operating margin, excluding other income, improved to 10.11%, the highest level recorded in the past eight quarters, indicating ..." }, { "title": "GKB Ophthalmics Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-ltd-is-rated-strong-sell-3834790", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GKBOphthalmicsL_mojoScore_3834790.png", "date": "2026-02-12 10:11:11", "description": "GKB Ophthalmics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 December 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook." } ], "total": 70, "sid": "360373", "stock_news_url": "https://www.marketsmojo.com/news/gkb-ophthalmics-360373" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "25-Mar-2026", "details": "Pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015 as amended from time to time the Trading Window for dealing / trading in the shares of the Company shall remain closed from April 012026 till completion of 48 hours after the declaration of the audited financial results of the Company for the quarter and financial year ended March 31 2026. Accordingly all the Promoters Directors and Designated Persons of he Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company during the periods of closure of Trading Window. Further the date of Board Meeting at which the said results will be considered shall be intimated in due course of time. Kindly take the information on record.", "source": "BSE" }, { "caption": "Outcome Of Independent Directors Meeting Held On March 18 2026", "datetime": "18-Mar-2026", "details": "A Seperate meeting of Independent Directors Meeting of the Company for the year 2025-26 was held pursuant to Regulation 25(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 and Section 149 (8) of the Companies Act 2013 read with Schedule IV (VII). The Independent Directors Meeting started at 3.00 P.M and ended at 4.10 P.M. on the same day. Kindly take the information on record.", "source": "BSE" }, { "caption": "Notice Of The Independent Directors Meeting", "datetime": "09-Mar-2026", "details": "Notice is hereby given that pursuant to Regulation 25 (3 & 4) of SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015 and Schedule IV clause VII of the Companies Act 2013 a separate meeting of the independent directors of GKB Ophthalmics Limited will be held on Wednesday March 18 2026 at the Registered office of the Company.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "GKB Ophthalmics Ltd has declared <strong>12%</strong> dividend, ex-date: 21 Sep 10", "dt": "2010-09-21", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Feb 9: Stock opens at Rs.53.33, down 2.82% amid broader Sensex gains

Feb 11: Stock rebounds sharply, gaining 5.68% to Rs.56.00

Feb 13: Quarterly results released; stock surges 10.92% to Rs.61.17

Feb 13: Week closes with 11.46% gain despite Sensex decline

Week Open

Rs.54.88

Week Close

Read full news article

Are GKB Ophthalmics Ltd latest results good or bad?

2026-02-13 19:54:33

GKB Ophthalmics Ltd's latest financial results for Q3 FY26 present a complex picture of operational performance. The company reported a significant revenue surge, with net sales reaching ₹56.79 crores, marking an 88.23% increase compared to the previous quarter. This growth represents the highest quarterly revenue in at least two years, indicating strong demand for its products. However, this impressive revenue growth did not translate into profitability, as the consolidated net profit fell to ₹0.44 crores, reflecting a 72.50% decline from the prior quarter. The operating margin also saw a substantial contraction, dropping to 2.39% from 10.11% in Q2 FY26, suggesting challenges in maintaining cost efficiency amidst rising sales. The PAT margin compressed to 1.25%, indicating difficulties in controlling costs despite increased sales volumes. The financial results highlight a concerning trend of deterioratin...

Read full news article

GKB Ophthalmics Ltd Reports Very Positive Quarterly Financial Performance Amid Market Volatility

2026-02-13 11:00:17

GKB Ophthalmics Ltd has demonstrated a marked improvement in its financial performance for the quarter ended December 2025, signalling a very positive shift in its growth trajectory despite broader market challenges. The company’s latest results reveal robust revenue expansion and a notable rise in profitability, contrasting with its historical trends and outperforming key market benchmarks.

Read full news article

GKB Ophthalmics Q3 FY26: Revenue Surge Masks Persistent Profitability Concerns

2026-02-13 09:25:33

GKB Ophthalmics Ltd., a Goa-based ophthalmic solutions manufacturer, reported a consolidated net profit of ₹0.44 crores for Q3 FY26, plunging 72.50% sequentially from ₹1.60 crores in Q2 FY26, despite an impressive 88.23% quarter-on-quarter revenue surge. The micro-cap healthcare services company, with a market capitalisation of ₹31.42 crores, saw its stock rally 13.04% to ₹62.34 following the results announcement, though it remains 32.02% below its 52-week high of ₹91.70.

Read full news article

Are GKB Ophthalmics Ltd latest results good or bad?

2026-02-12 19:45:53

GKB Ophthalmics Ltd's latest financial results for Q2 FY26 present a complex picture of operational performance. The company reported a consolidated net profit of ₹1.60 crores, which marks a significant turnaround from a net loss of ₹1.02 crores in the previous quarter, though it reflects a substantial decline of 231.15% year-on-year. This profit, while positive in the context of the previous quarter, highlights the volatility in the company's financial performance. On the revenue front, GKB Ophthalmics generated ₹30.17 crores, which represents a quarter-on-quarter decline of 6.62% compared to ₹32.31 crores in the previous quarter, but shows a year-on-year growth of 15.42%. This revenue growth suggests some resilience in topline performance despite the recent quarterly drop. The operating margin, excluding other income, improved to 10.11%, the highest level recorded in the past eight quarters, indicating ...

Read full news article

GKB Ophthalmics Ltd is Rated Strong Sell

2026-02-12 10:11:11

GKB Ophthalmics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 December 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article